All research
2026-06-18 PubMed

Codonopsis pilosula polysaccharide attenuates Brucella OMP19-induced macrophage inflammation via ATP2A1, cell adhesion, and calcium signaling.

Codonopsis pilosula polysaccharide attenuates the inflammatory response in macrophages induced by Brucella abortus outer membrane protein 19 via regulating ATP2A1 to modulate cell adhesion and calcium signaling.

Background

Brucellosis, a significant zoonotic disease, poses a global health challenge, primarily due to the pathogen's ability to evade macrophage-mediated killing and trigger a detrimental pro-inflammatory cytokine storm. Current treatments often struggle with bacterial persistence and immune-mediated tissue damage. Polysaccharides from traditional medicinal plants, like Codonopsis pilosula, have shown promise in modulating immune responses and inhibiting inflammation, making them attractive candidates for exploring novel therapeutic strategies against persistent infections and associated inflammatory pathologies.

Study Design

Researchers investigated the anti-inflammatory effects of Codonopsis pilosula polysaccharides (CPPS) against Brucella abortus outer membrane protein 19 (OMP19)-induced inflammation. The study employed both in vivo and in vitro models. In vivo, CPPS was administered to an unspecified animal model of brucellosis, with tissue damage and protein expression (HMGB1, E-cadherin, paxillin) as key endpoints. In vitro, macrophages were stimulated with OMP19, and the impact of CPPS on various signaling pathways (SYK/FAK/AKT, PKC, WNT-1), cytokine profiles (TNF-α, IL-6, IL-10), cell adhesion markers, and intracellular calcium (Ca2+) concentration was assessed. Transcriptome sequencing identified ATP2A1 as a key gene, further validated by knockdown experiments to confirm its role in CPPS's anti-inflammatory actions.

Results

CPPS demonstrated significant anti-inflammatory effects across both in vivo and in vitro models. In vivo, CPPS markedly alleviated tissue damage and downregulated the expression of HMGB1, E-cadherin, and paxillin. In vitro, CPPS inhibited SYK/FAK/AKT phosphorylation, PKC activation, and WNT-1 signaling pathway transduction. The cytokine profile was also modulated, with CPPS downregulating pro-inflammatory cytokines TNF-α and IL-6 while increasing the anti-inflammatory cytokine IL-10. Furthermore, CPPS decreased the expression levels of E-cadherin and paxillin and reduced the intracellular calcium ion (Ca2+) concentration. Transcriptome sequencing identified ATP2A1 as a key differentially expressed gene. > Knockdown experiments confirmed that CPPS exerts its anti-inflammatory effects by regulating ATP2A1, highlighting a novel mechanism involving cell adhesion and calcium signaling modulation.

Key Findings

  • CPPS significantly alleviated tissue damage in an in vivo brucellosis model.
  • CPPS downregulated HMGB1, E-cadherin, and paxillin expression in vivo.
  • CPPS inhibited SYK/FAK/AKT phosphorylation, PKC activation, and WNT-1 signaling in vitro.
  • CPPS modulated cytokine profiles, decreasing TNF-α and IL-6 while increasing IL-10.
  • CPPS reduced intracellular Ca2+ concentration and regulated ATP2A1 expression.

Why It Matters

This research highlights Codonopsis pilosula polysaccharide (CPPS) as a potential therapeutic agent for brucellosis, offering a novel strategy to mitigate the severe inflammatory response associated with the disease. By targeting ATP2A1 and modulating cell adhesion and calcium signaling, CPPS could help prevent the destructive cytokine storm and tissue damage characteristic of brucellosis. While this is preclinical work, it opens avenues for developing natural product-derived interventions that could be integrated into existing treatment protocols, potentially reducing reliance on antibiotics alone or mitigating their side effects. Further research is needed to translate these findings into human-applicable protocols, including dose-response studies and safety profiles in relevant animal models, before clinical trials can be considered.


codonopsis-pilosula-polysaccharide brucellosis inflammation macrophages immunomodulation atp2a1
Source: pubmed:42311667 · Ingested 2026-06-18 · Digest: gemini-2.5-flash